One-Year Medication Adherence and Persistence in Rheumatoid Arthritis in Clinical Practice: A Retrospective Analysis of Upadacitinib, Adalimumab, Baricitinib, and Tofacitinib

por Bergman, Martin, Chen, Naijun, Thielen, Richard, Zueger, Patrick
Publicado 2023

Evaluation of Adherence and Persistence Differences Between Adalimumab Citrate-Free and Citrate Formulations for Patients with Immune-Mediated Diseases in the United States

por Bergman, Martin, Patel, Pankaj, Chen, Naijun, Jing, Yonghua, Saffore, Christopher D.
Publicado 2020

The efficacy and safety of glucokinase activators for the treatment of type-2 diabetes mellitus: A protocol for systematic review and meta-analysis

por Gao, Qian, Zhang, Wenjun, Li, Tingting, Yang, Guojun, Zhu, Wei, Chen, Naijun, Jin, Huawei
Publicado 2021

The efficacy and safety of glucokinase activators for the treatment of type-2 diabetes mellitus: A meta-analysis

por Gao, Qian, Zhang, Wenjun, Li, Tingting, Yang, Guojun, Zhu, Wei, Chen, Naijun, Jin, Huawei
Publicado 2021

Interrelationship between 2019-nCov receptor DPP4 and diabetes mellitus targets based on protein interaction network

por Gao, Qian, Zhang, Wenjun, Li, Tingting, Yang, Guojun, Zhu, Wei, Chen, Naijun, Jin, Huawei
Publicado 2022

Economic Burden of Fatigue in Inflammatory Bowel Disease

por Ananthakrishnan, Ashwin N, Desai, Raj, Lee, Wan-Ju, Griffith, Jenny, Chen, Naijun, Loftus, Edward V
Publicado 2023

ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity...

por van der Heijde, Désirée, Joshi, Avani, Pangan, Aileen L., Chen, Naijun, Betts, Keith, Mittal, Manish, Bao, Yanjun
Publicado 2016

Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study

por Van den Bosch, Filip, Ostor, Andrew J. K., Wassenberg, Siegfried, Chen, Naijun, Wang, Chen, Garg, Vishvas, Kalabic, Jasmina
Publicado 2017

Erratum to: Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study

por Van den Bosch, Filip, Ostor, Andrew J. K., Wassenberg, Siegfried, Chen, Naijun, Wang, Chen, Garg, Vishvas, Kalabic, Jasmina
Publicado 2017

Development and initial validation of the HS‐IGA: a novel hidradenitis suppurativa‐specific investigator global assessment for use in interventional trials

por Garg, Amit, Zema, Carla, Kim, Katherine, Gao, Weihua, Chen, Naijun, Jemec, Gregor B.E., Kirby, Joslyn, Thorlacius, Linnea, Villumsen, Bente, Ingram, John R.
Publicado 2022

Association of joint space narrowing with impairment of physical function and work ability in patients with early rheumatoid arthritis: protection beyond disease control by adalimu...

por Smolen, Josef S, van der Heijde, Désirée M, Keystone, Edward C, van Vollenhoven, Ronald F, Goldring, Mary B, Guérette, Benoît, Cifaldi, Mary A, Chen, Naijun, Liu, Shufang, Landewé, Robert B M
Publicado 2013

Effect of Adalimumab on Clinical Outcomes and Health-related Quality of Life Among Patients With Ulcerative Colitis in a Clinical Practice Setting: Results From InspirADA

por Travis, Simon, Feagan, Brian G, Peyrin-Biroulet, Laurent, Panaccione, Remo, Danese, Silvio, Lazar, Andreas, Robinson, Anne M, Petersson, Joel, Pappalardo, Brandee L, Bereswill, Mareike, Chen, Naijun, Wang, Song, Skup, Martha, Thakkar, Roopal B, Chao, Jingdong
Publicado 2017